Related Experiment Video

Updated: Jul 8, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

[A multicenter study of 7-day cefditoren pivoxil treatment for group A streptococcal infection]

Hiroshi Sakata1

  • 1Department of Pediatrics, Asahikawa Kosei Hospital.

The Japanese Journal of Antibiotics
|January 18, 2008
PubMed

Insights

Cefditoren pivoxil effectively treated group A streptococcal infections in children, with most symptoms improving. However, some children experienced recurrent infections, indicating a need for further monitoring.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Pharmacology

Context:

  • Group A Streptococcus (GAS) is a common bacterial pathogen in children.
  • Antibiotic resistance and treatment efficacy are critical concerns for GAS infections.
  • Cefditoren pivoxil is a third-generation cephalosporin antibiotic.

Purpose:

  • To evaluate the clinical efficacy and bacterial eradication of cefditoren pivoxil in children with group A streptococcal infections.
  • To assess the occurrence of recurrent infections and complications following treatment.

Summary:

  • A prospective multicenter study evaluated 90 children with GAS infections treated with cefditoren pivoxil (9 mg/kg/day tid for 7 days).
  • Clinical efficacy was observed in 79 children, with symptom amelioration.
  • Four children had persistent GAS at therapy end, and 5 experienced recurrence within a month; isolates were identical to initial strains.
  • No complications were reported, but 1 child experienced diarrhea.

Impact:

  • Cefditoren pivoxil demonstrates clinical efficacy in treating pediatric GAS infections.
  • Recurrence of GAS infection is possible despite initial treatment, necessitating follow-up.
  • The study provides data on the safety and effectiveness of cefditoren pivoxil in a pediatric population.

Related Concept Videos

Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...